[1]
“Clinical and functional predictors that cause a decrease of indicators of morning blood pressure profile in antihypertensive telmisartan-based therapy”, Biomed. Res. Ther., vol. 7, no. 9, pp. 3985–3995, Sep. 2020, doi: 10.15419/bmrat.v7i9.630.